126 related articles for article (PubMed ID: 1981946)
1. Neural transplantation in mouse Parkinson's disease.
Shimizu K; Yamada M; Matsui Y; Tamura K; Moriuchi S; Mogami H
Stereotact Funct Neurosurg; 1990; 54-55():353-7. PubMed ID: 1981946
[TBL] [Abstract][Full Text] [Related]
2. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway--III. Reversal by embryonic nigral dopamine grafts.
Sirinathsinghji DJ; Dunnett SB; Northrop AJ; Morris BJ
Neuroscience; 1990; 37(3):757-66. PubMed ID: 2247221
[TBL] [Abstract][Full Text] [Related]
3. Effects of graft pooling of foetal rat and mouse tissue and immunosuppression in the 6-hydroxydopamine rat model of Parkinson's disease.
Schwarz SC; Sauer H; Oertel WH; Earl CD; Kupsch AR
Exp Brain Res; 1997 Jun; 115(1):71-82. PubMed ID: 9224835
[TBL] [Abstract][Full Text] [Related]
4. Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.
Terpstra BT; Collier TJ; Marchionini DM; Levine ND; Paumier KL; Sortwell CE
J Neurosci Methods; 2007 Oct; 166(1):13-9. PubMed ID: 17706789
[TBL] [Abstract][Full Text] [Related]
5. Behavioral changes associated with grafts of embryonic ventral mesencephalon tissue into the striatum and/or substantia nigra in a rat model of Parkinson's Disease.
Johnston RE; Becker JB
Behav Brain Res; 1999 Oct; 104(1-2):179-87. PubMed ID: 11125737
[TBL] [Abstract][Full Text] [Related]
6. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J
Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602
[TBL] [Abstract][Full Text] [Related]
7. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
Bentlage C; Nikkhah G; Cunningham MG; Björklund A
Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
[TBL] [Abstract][Full Text] [Related]
8. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants.
Gaillard A; Decressac M; Frappé I; Fernagut PO; Prestoz L; Besnard S; Jaber M
Neurobiol Dis; 2009 Sep; 35(3):477-88. PubMed ID: 19616502
[TBL] [Abstract][Full Text] [Related]
9. A comparison of solid intraventricular and dissociated intraparenchymal fetal substantia nigra grafts in a rat model of Parkinson's disease: impaired graft survival is associated with high baseline rotational behavior.
Heim RC; Willingham G; Freed WJ
Exp Neurol; 1993 Jul; 122(1):5-15. PubMed ID: 8101821
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival of grafted cells, dopamine synthesis/release, synaptic connections, and functional recovery after transplantation of fetal nigral cells in rats with unilateral 6-OHDA lesions in the nigrostriatal dopamine pathway.
Nishino H; Hashitani T; Kumazaki M; Sato H; Furuyama F; Isobe Y; Watari N; Kanai M; Shiosaka S
Brain Res; 1990 Nov; 534(1-2):83-93. PubMed ID: 1981488
[TBL] [Abstract][Full Text] [Related]
11. [Transplant-induced recovery from 6-OHDA lesions of the nigro-striatal dopamine neurons in mice].
Shimizu K; Tsuda N; Matsui Y; Okamoto Y; Miyao Y; Yamada M; Ikeda T; Hatanaka H; Mogami H
No To Shinkei; 1988 Jul; 40(7):623-8. PubMed ID: 3224037
[TBL] [Abstract][Full Text] [Related]
12. Addition of allogeneic spleen cells causes rejection of intrastriatal embryonic mesencephalic allografts in the rat.
Duan WM; Brundin P; Widner H
Neuroscience; 1997 Mar; 77(2):599-609. PubMed ID: 9472415
[TBL] [Abstract][Full Text] [Related]
13. The nigrostriatal dopaminergic system in MPTP-treated mice shows more prominent recovery by syngeneic adrenal medullary graft than by allogeneic or xenogeneic graft.
Date I; Felten SY; Felten DL
Brain Res; 1991 Apr; 545(1-2):191-8. PubMed ID: 1860045
[TBL] [Abstract][Full Text] [Related]
14. [Fate of human fetal dopamine neurons transplanted into rhesus monkey model of Parkinson's disease: a tyrosine hydroxylase immunocytochemical study].
Jiang ZH; Liu ZG; Chen SD; Zhou WB; Cai J; Ni ZM; Zhou CF
Sheng Li Xue Bao; 1995 Feb; 47(1):31-7. PubMed ID: 7784896
[TBL] [Abstract][Full Text] [Related]
15. Sequential intrastriatal grafting of allogeneic embryonic dopamine-rich neuronal tissue in adult rats: will the second graft be rejected?
Duan WM; Widner H; Björklund A; Brundin P
Neuroscience; 1993 Nov; 57(2):261-74. PubMed ID: 7906872
[TBL] [Abstract][Full Text] [Related]
16. CNS immunological modulation of neural graft rejection and survival.
Borlongan CV; Stahl CE; Cameron DF; Saporta S; Freeman TB; Cahill DW; Sanberg PR
Neurol Res; 1996 Aug; 18(4):297-304. PubMed ID: 8875445
[TBL] [Abstract][Full Text] [Related]
17. Sequential intracerebral transplantation of allogeneic and syngeneic fetal dopamine-rich neuronal tissue in adult rats: will the first graft be rejected?
Widner H; Brundin P
Cell Transplant; 1993; 2(4):307-17. PubMed ID: 8162272
[TBL] [Abstract][Full Text] [Related]
18. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Agrawal AK
Neurosci Lett; 2006 May; 398(1-2):44-9. PubMed ID: 16423459
[TBL] [Abstract][Full Text] [Related]
19. Transplants in Parkinson's disease.
Lindvall O
Eur Neurol; 1991; 31 Suppl 1():17-27. PubMed ID: 1855521
[TBL] [Abstract][Full Text] [Related]
20. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
Strömberg I; Kehr J; Andbjer B; Fuxe K
Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
